SecBot SecBot
SECBOTREPLAY Home › Report › TRAW

TRAW · S-1 effective, 879% dilution

Traws Pharma, Inc. · EFFECT filed Nov 13, 2026 at 00:15 ET

At the news

BEARISHIMPACT 7/10

EFFECT filed Nov 13, 2026 at 00:15 ET

The SEC declared effective Traws Pharma's S-1 registration (File No. 333-299644) on November 12, 2026, covering up to 135,135,135 shares for resale by Roth Principal Investments under a committed equity facility. This allows the company to sell up to $50 million of newly issued shares at a 6% discount to VWAP over 36 months, with the registered shares representing approximately 879% of current outstanding shares, creating severe dilution risk.

  • S-1 registration declared effective on November 12, 2026
  • Registration covers 135,135,135 shares for resale by Roth Principal Investments, LLC
  • Shares represent approximately 879% of current outstanding shares
  • Committed equity facility allows Traws to sell up to $50 million of newly issued shares

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access